Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman,

Slides:

Advertisements

Similar presentations

Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study Evgenij V Potapov, MD, Heinz R Zurbrügg,

Advertisements

The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass Russell E Anderson, MD, PhD, Lars-Olof Hansson, MD, PhD,

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration Jean-Olivier Defraigne, MD, PhD,

Immunology and failure of valved allografts in children

Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study Song Wan, MD, PhD, Jean-Louis.

Modified Ultrafiltration Attenuates Dilutional Coagulopathy in Pediatric Open Heart Operations Robert H Friesen, David N Campbell, David R Clarke, Michael.

Randomized Comparison Between Normothermic and Hypothermic Cardiopulmonary Bypass in Pediatric Open-Heart Surgery Massimo Caputo, MD, Simon Bays, Chris.

CTSNet: a unique educational vehicle

James L Zellner, MD, Scott B Kribbs, BS, B

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.

Sivelestat Attenuates Lung Injury in Surgery for Congenital Heart Disease With Pulmonary Hypertension Norikazu Nomura, MD, PhD, Miki Asano, MD, PhD,

Effects of Depletion of Leukocytes and Platelets on Cardiac Dysfunction After Cardiopulmonary Bypass Yukio Chiba, Kouichi Morioka, Ryusuke Muraoka, Akio.

Total Liquid Ventilation Reduces Lung Injury in Piglets After Cardiopulmonary Bypass Lijun Jiang, MD, Qiang Wang, MD, Yinglong Liu, MD, Ming Du, MD, Xiangdong.

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD,

Intravenous Diltiazem and Acute Renal Failure After Cardiac Operations

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Synergistic Immunosuppression Caused by High-Dose Methylprednisolone and Cardiopulmonary Bypass Hisanori Mayumi, MD, Qui-Wei Zhang, MD, Atsuhiro Nakashima,

An Analysis of Oxygen Consumption and Oxygen Delivery in Euthermic Infants After Cardiopulmonary Bypass With Modified Ultrafiltration Jia Li, MD, PhD,

William T. Mahle, MD, Emilia Matthews, MS, Kirk R. Kanter, MD, Brian E

Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass Martin Strüber, MD, Jochen T Cremer, MD, Bernhard.

Origins of the Cardiothoracic Surgery Network (CTSNet)

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Hypogammaglobulinemia after cardiopulmonary bypass in infants

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

Coronary Microvascular Reactivity After Ischemic Cold Storage and Reperfusion Charles O Murphy, MD, Pan- Chih, MD, John Parker Gott, MD, Robert A Guyton,

Support Your Specialty

Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children

David R Lawrence, FRCS, Jatin B Desai, FRCS(CTh)

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Infant cardiopulmonary bypass: a procoagulant state

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Platelet and Neutrophil Activation During Cardiac Surgical Procedures: Impact of Cardiopulmonary Bypass David S Morse, David Adams, Barbarajean Magnani

Nilanjan Chaudhuri, Mark St.J Hickey The Annals of Thoracic Surgery

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting Josef.

C.Thomas Wass, David G Cable, Hartzell V Schaff, William L Lanier

Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass Nobuhiko Hayashida, MD, PhD, Hiroshi Tomoeda, MD, Takeshi Oda, MD,

No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits Christian Olsson, MD, Agneta Siegbahn, MD, PhD,

Ronald A. Bronicki, MD, Carl L. Backer, MD, Harris P

Cardiac cannulation, sodium and water balance, and ANF plasma levels

Stany Sandrio, MD, Ariawan Purbojo, MD, Robert A

Inflammatory Mediators in Adults Undergoing Cardiopulmonary Bypass: Comparison of Centrifugal and Roller Pumps Saeed Ashraf, John Butler, Yi Tian, Dahlia.

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass Jeffrey M.

Ko Bando, MD, Kyung Sun, MD, Robert S Binford, MD, Thomas G Sharp, MD

Is there a role for pneumonectomy in pulmonary metastases?1

Anthony P.C Yim, MD, Song Wan, MD, PhD, Tak Wai Lee, Ahmed A Arifi

Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost Michael J Ray, PhD, Mark F O’Brien

Intermittent Warm Blood Cardioplegia Preserves Myocardial β-Adrenergic Receptor Function Massimo Chello, Pasquale Mastroroberto, Vincenzo De Amicis,

Effect of Nitric Oxide Gas on Platelets During Open Heart Operations

Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit Michael J Ray, PhD, Majella M Hales,

Role of limited posterior thoracotomy for open-heart surgery in the current era Krishnanaik Shivaprakasha, Kona Samba Murthy, Robert Coelho, Ravi Agarwal,

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Serum S100β release after coronary artery bypass grafting: roller versus centrifugal pump Saeed Ashraf, Kausik Bhattacharya, Sunny Zacharias, Pradeep.

Reduced inotropic support after aprotinin therapy during pediatric cardiac operations Carl F Wippermann, MD, Franz X Schmid, MD, Balthasar Eberle, MD,

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Roderick W Landymore, MD, Alexander J Bayes, MD, J

The Impact of New Technology on Cardiothoracic Surgical Practice

Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury Christine S Rinder, MD, Manuel Fontes, MD,

Gary E. Hill, MD, FCCMa,b, Anselmo Alonso, MDc, John R

Robert J Frumento, MS, MPH, Catherine M

Safety of low hematocrits during cardiopulmonary bypass

Myocardial, Inflammatory, and Stress Responses in Off-Pump Coronary Artery Bypass Graft Surgery With Thoracic Epidural Anesthesia Massimo Caputo, MD,

Presentation transcript:

Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman, Roman Pohorecki The Annals of Thoracic Surgery Volume 65, Issue 1, Pages 66-69 (January 1998) DOI: 10.1016/S0003-4975(97)01037-0

Fig. 1 Interleukin-10 (IL-10) plasma levels (pg/mL) (mean ± standard error of the mean [SEM]) at baseline (time period 1), 1 hour (time period 2), and 24 hours (time period 3) after cardiopulmonary bypass in groups A and C. (∗p < 0.05, compared with the same group at baseline; †p < 0.05, compared with group C at the same time period.) The Annals of Thoracic Surgery 1998 65, 66-69DOI: (10.1016/S0003-4975(97)01037-0)